Bone Fragility Fractures in Hemodialysis Patients: Croatian Surveys by Iva Šimunović et al.
71
have shown that there is an increased risk, incidence and 
prevalence of bone fractures, particularly hip fractures 
among hemodialysis patients7–10.
It is well known that age is one of greatest risks of 
fragility bone fractures in general population11. The world-
wide population is aging and dialysis patients are also 
increasingly older12. In the general population osteoporo-
sis, a common disorder of aging is the main cause of fragil-
ity bone fractures13. Renal osteodystrophy and superim-
posed age-related bone changes, i.e. osteoporosis, put CKD 
patients in a very high risk group.
Interestingly, only in the last 10 years has the nephrol-
ogy community had suffi cient data on risk factors for bone 
fractures in hemodialysis patients. During the last 10 
years, there were several studies, particularly in the Unit-
ed States regarding incidence, prevalence and risk factors 
of bone fractures among hemodialysis patients7–10,14. The 
primary objective of this multicentric cross-sectional 
More than 60 years ago the term »renal osteodystro-
phy« was used to describe bone disease associated with 
chronic renal failure1,2. Since then, prevention and treat-
ment of bone disease in chronic kidney disease (CKD) is 
a great challenge for many nephrologists3. At the same 
time due to broad basic and clinical research it was recog-
nized that bone disease is only one consequence of dis-
turbed mineral metabolism. In 2006, a new defi nition was 
established »Chronic Kidney Disease – Mineral and Bone 
Disorder« (CKD-MBD). It describes a very broad clinical 
syndrome, i.e. a systemic disorder of mineral and bone 
metabolism due to chronic kidney disease manifested by 
abnormalities of calcium, phosphorous, PTH and vitamin 
D; abnormalities in bone turnover, mineralization, vol-
ume, strength or linear growth and soft tissue and vascu-
lar calcifi cation4,5. Renal osteodystrophy, as a part of 
CKD-MBD, is a multifactorial disorder of bone metabo-
lism. One of the most important clinical consequences of 
renal osteodystrophy is bone fracture6. Several studies 
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A B S T R A C T
Disturbances of bone mineral metabolism are common complications of chronic kidney disease with bone fractures as 
one of the most important consequences. The aim of this study was to estimate prevalence of bone fractures among Croa-
tian hemodialysis patients and to determine the possible fracture risk. The study was carried out in 767 hemodialysis 
patients from nine Croatian hemodialysis centers. Demographic, laboratory and bone fracture data were collected from 
medical records as well as therapy with vitamin D analogs. Fragility fractures were defi ned according to the World Health 
Organization defi nition. In 31 patient a total of 36 fractures were recorded. The prevalence of patients with bone fractures 
was 4.0%. The mean age of patients with fractures was 68.6 years. There were 9 male and 22 female patients with frac-
tures. The mean hemodialysis duration was 63.3 months. Among all fractures the most common were hip fractures (39%) 
followed by forearm fractures (22%). This is the fi rst study regarding epidemiology of bone fractures in Croatian hemodi-
alysis patients. The prevalence of patients with bone fractures in our group of hemodialysis patients is high. Fractures 
were more frequent among women and older patients, patients who have been longer on dialysis and in patients with 
higher concentration of PTH.
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study was to investigate the prevalence of patients with 
skeletal fractures among Croatian hemodialysis patients 
and to investigate the biochemical markers related to bone 
fractures and try to determine the possible fracture risk 
among hemodialysis patients.
Subjects and Methods
The study was carried out in prevalent hemodialysis 
patients from nine Croatian hemodialysis centres from 
September 2009 to January 2010. The data about bone 
fragility fractures was collected from the medical records 
or by patient interviews by facility physicians. The frac-
tures occurred after the onset of hemodialysis were taken 
into consideration. Low-trauma, i.e. fragility fractures 
were deﬁ ned according to the World Health Organization 
deﬁ nition: fractures that were caused by minor trauma or 
by fall from a maximum height equal to or below the up-
right position of the patient. Demographic parameters 
which included gender, age, presence of diabetes mellitus 
and date of hemodialysis onset were collected from medi-
cal records. Laboratory data included serum levels of PTH 
(pg/ml, normal range 6–64 pg/ml), calcium (mmol/L), 
phosphate (mmol/L) as well as alkaline phosphathase 
(U/L) taken from a patient not more than two months 
before the occurrence of the bone fracture were also col-
lected as well as bone fracture data: the date of occurrence 
of the fracture and the location of fracture (hip, forearm, 
upper arm, rib, vertebrae, lower leg, femur or hand). Data 
about therapy with vitamin D (calcitriol per os) or analogs 
of vitamin D (paricalcitol i.v.) was also collected. All pa-
tients were on hemodialysis four hours three times per 
week. Standard dialyzate calcium concentration in Croa-
tian dialysis centres is 1.5 mmol/l. Aluminium hydroxide 
has not been used as phosphate binder in Croatia for more 
than 20 years. Calcium carbonate or sevelamer hydrochlo-
ride is used as phosphate a binder (Table 1).
All data management and analyses were conducted us-
ing Microsoft Excel. Results are given as the means and 
standard deviations (SD) or percentages. Results are con-
sidered to be signiﬁ cant at the 5% critical level (p<0.05). 
The prevalence of patients with fractures is calculated as 
the percentage of patients with fractures of a total number 
of hemodialysis patients. We used bivariate analyses (t-
test, Fisher’s test) to examine differences between PTH 
values among forearm and hip fractures, fractures of the 
predominantly spongious bones (fractures of vertebra and 
hip) and predominantly compact bones (fractures of ribs, 
upper arm, forearm, femur and lower leg). We deﬁ ned 
PTH values <180 pg/ml as relative hypoparathyroidism, 
and PTH values >300 pg/ml as secondary hyperparathy-
roidism.
Results
767 hemodialysis patients were included in this study. 
In 31 patients a total of 36 fractures were recorded. 26 
patients suffered one and ﬁ ve patients suffered two frac-
tures. The prevalence of patients with bone fractures was 
4.0%. The mean age of patients with fractures was 
68.6±9.1 years (range 46–87). In patients less than 40 
years of age no bone fractures were observed. 8 bone frac-
tures (22%) were recorded in patients aged between 41 and 
60 as well as 28 bone fractures (78%) in patients older 
than 60 years. (Figure 1) There were 9 (29%) male and 22 
(71%) female patients. Only 6 (19%) patients were diabet-
ics. The mean hemodialysis duration was 63.3±37.2 
months (range 0–265). Fractures were more often ob-
served in patients on hemodialysis for more than ﬁ ve 
years, i.e. 50% of all bone fractures were observed in pa-
tients on hemodialysis for more than 60 months (Figure 
2). Among all fractures there were 14 hip fractures (39%), 
eight forearm fractures (22%), ﬁ ve upper arm fractures 
(14%), four femur fractures (11%), two lower leg fractures 
TABLE 1
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF THE 
PATIENTS WITH BONE FRACTURES
Age (years) 68.6±10.8
Gender (female/male) 2/9
HD vintage (months) 63.3±54.8
Diabetes mellitus (%) 19
Vitamin D therapy (%) 52
Sevelamer hydrochloride (%) 29
Ca (mmol/L) 2.25±0.23
P (mmol/L) 1.57±0.55
Ca x P (mmol2/L2) 3.13±3.28
PTH (pg/ml) 376.97±446.07
tAP (U/L) 172.89±170.91
Data are X±SD or number (%)
Fig. 1. Prevalence of fractures depending on age of hemodialysis 
patients.
Fig. 2. Prevalence of fractures depending on HD vintage.
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(5%) and one rib, vertebrae and hand fracture each (3%) 
(Figure 3). Ten bone fractures (28%) were associated with 
PTH levels <180 pg/ml and 12 bone fractures (33%) with 
PTH between 181 and 300 pg/ml; 14 (39%) with PTH > 
300 pg/ml (Figure 4). Patients with hip fractures had the 
highest level of PTH – 541.4 (range 23–1790) pg/ml. The 
lowest PTH was in patients with forearm fractures 198.5 
(range 57.3–310.9) pg/ml. The mean level of PTH among 
fractures of predominantly spongious bones, e.g. ribs, ver-
tebre was 517.7 (range 23–2017) pg/ml and among frac-
tures of predominantly compact bones (forearm and hip) 
276.4 (range 30.4–726.1) pg/ml. The differences were not 
statistically signiﬁ cant due to very low PTH levels in two 
patients with hip fractures. Sixteen patients (52%) with 
bone fractures were on therapy with calcitriol or parical-
citrol at the time of the fractures.
Discussion
There is no doubt that incidence and prevalence of fra-
gility bone fractures in hemodialysis patients is high and 
much higher than in general population7,9.
This is ﬁ rst study regarding epidemiology of bone frac-
tures in Croatian hemodialysis patients. Croatia, a small 
country with slightly less than 4.5 million inhabitants15 
has a relatively high incidence and prevalence of patients 
on renal replacement therapy. In 2008, there were 2743 
patients on hemodialysis (prevalence 618 pmp) and 244 on 
peritoneal dialysis (prevalence 55 pmp). The median age 
of patients starting hemodialysis in 2008 was 67 years16. 
There were 767 patients from 9 dialysis centres in our 
study group – approximately 28% of hemodialysis patients 
in Croatia. We think that the number of patients is repre-
sentative enough to estimate the prevalence of fragility 
bone fractures in Croatian hemodialysis patients. The 
prevalence is large, i.e. 4.0%. Since the total number of 
patients and fractures was nevertheless small, we did not 
particularly examine the prevalence of individual frac-
tures. However, the most frequent type of fracture was a 
fracture of the hip, followed, interestingly, by fractures of 
the upper extremities. The average age of patients with 
bone fractures (68.6 years) is somewhat greater than the 
median of patients who started dialysis in 2008, 67 
years16. As was expected, fractures were more frequent 
among women and among older patients. Patients who 
have been longer on dialysis and, in our investigation, pa-
tients with a higher concentration of PTH (secondary hy-
perparathyroidism) are especially threatened.
Low levels of PTH (relative hypoparathyroidism) are 
in CKD patients connected with low bone turnover i.e., 
adynamic bone disease and PTH level >300 pg/ml with 
high turnover. Although it is known that PTH acts more 
on a compact bone17,18, we did not prove that the fracture 
incidence of compact bone is higher in patients with sec-
ondary hyperparathyroidism. The cause might be the 
relatively small number of patients and sometimes, as in 
our group, two patients with very low values of PTH (i.e. 
suspected low bone turnover) who had fractures of the 
forearm.
Unfortunately, there is no accurate data on the inci-
dence and prevalence of bones fractures among the gen-
eral population in Croatia. Some studies estimate that the 
incidence of fractures in persons older than 60 years to be 
<0.1%, which matches the incidence in the developed Eu-
ropean countries19,20. Therefore, the incidence and preva-
lence of fractures in Croatian dialysis patients is signiﬁ -
cantly greater than in the general population. Age, gender, 
duration of hemodialysis, and an increased concentration 
of PTH are linked to a higher risk of bone fracture in our 
patients than the prevalence of bone fractures in the gen-
eral population.
Our results match the results of other studies until 
now7,8,9. In the majority of studies age, gender, and dura-
tion of dialysis are linked to the risk of bone fracture. 
Although in some studies hyperparathyroidism has been 
associated with lower bone mass density at all sites21,22, in 
other studies both hypo- and hyperparathyroidism were 
linked to fractures14,22,23 and in our patients hyperparathy-
roidism still holds a greater risk for the appearance of 
fractures.
Our work has several shortcomings. It was an obser-
vational study and we obtained data on fractures on the 
basis of medical history or from medical documentation. 
In our study we did not examine other factors that are 
linked to an increased risk of bones fractures among di-
alysis patients, such as treatments with anti-depressives, 
low levels of albumin, low levels of vitamin D or meta-
Fig. 3. Localization of bone fractures among hemodialysis 
patients.
Fig. 4. Prevalence of bone fractures depending on PTH values.
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static calciﬁ cation. Nevertheless, we think that this type 
of work will be able to contribute to the recognition of the 
signiﬁ cance of bone fractures in dialysis patients. Our 
next step, which is in the preparatory phase, is to include 
a larger number of centers and patients, to carry out a 
preliminary investigation during at least the next two 
years and to examine all of the known risk factors: PTH 
level, Albumin concentration, 25 OHD level, drug treat-
ment etc.
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UČESTALOST PRIJELOMA KOSTIJU U BOLESNIKA NA HEMODIJALIZI: HRVATSKI REZULTATI
S A Ž E T A K
Poremećaj mineralnog metabolizma kostiju česta je komplikacija kroničnog bubrežnog zatajenja s povećanim rizikom 
prijeloma kostiju. Cilj ovog istraživanja je određivanje učestalosti bolesnika s prijelomima kostiju među hrvatskim bole-
snicima na hemodijalizi te ispitivanje čimbenika rizika za nastanak prijeloma. Istraživanje je provedno među 797 
bolesnika na hemodijalizi u 9 hrvatskih centara za dijalizu. Pregledom medicinske dokumentacije zabilježeni su kliničkom 
obradom dokazani prijelomi kostiju, demografski podatci, laboratorijski podatci te podatci o terapiji analozima vitamina 
D. U tridesetjednog bolesnika zabilježeno je tridesetšest prijeloma. Učestalost bolesnika s prijelomima kostiju je 4,0%. 
Srednja dob bolesnika s prijelomima je 68,6 godina. Prijelomi su zabilježeni u devet muškaraca i dvadesetdvije žene. 
Srednje trajanje dijalize je 63,3 mjeseca. Najčešće zabilježeni prijelomi su prijelomi kuka (39%) i podlaktice (22%). 16 
bolesnika s prijelomima je bilo na terapiji kalcitriolom ili parikalcitriolom u vrijeme nastanka prijeloma. Ovo je prvo 
istraživanje o prijelomima kod hrvatskih bolesnika na hemodijalizi. Učestalost bolesnika s prijelomima je visoka, prijelo-
mi su učestaliji kod starijih bolesnika, žena, bolesnika koji su duže na dijalizi i bolesnika povišenim vrijednostima PTH.
